Summers Value Partners Q3 2025 Partner Letter [Seeking Alpha]
Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA's 75% Growth in U.S. Prostacyclin Revenue [Yahoo! Finance]
Liquidia (NASDAQ:LQDA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Liquidia (NASDAQ:LQDA) had its price target raised by analysts at Needham & Company LLC from $36.00 to $52.00. They now have a "buy" rating on the stock.
Liquidia (NASDAQ:LQDA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock.